Company / Total Debt
Avalo Therapeutics, Inc. Total Debt History
FY2017-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$14.3M
FY2018
5-year range
-
FY2017-FY2018
Trend
-
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$14M in FY2018.
Total Debt over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $14.3M | - |
| FY2017 | $0 | - |
As of FY2018 · SEC Form 10-K · Last checked Jun 21, 2026